Home
Novartis

Novartis Market Share Analysis for July 2026

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

Health > Biotechnology and Pharmaceuticals

Domainnovartis.com.sg

Year Founded1996

Employees> 10001

Annual Revenue> $1B

Novartis

Novartis (including company regionals)

novartis.com.sg

See more website traffic and engagement information

Novartis Revenue up to July 2026 is > 1B

revenue generated by Novartis top domains

Novartis top domains revenue over 3 years

Revenue for Novartis top domains

novartis.com.sg> 1B

See more with Sales Intelligence

Novartis Stock price in July 2026

Novartis stock is traded under the ticker #NVS. Below you can review Novartis stock performance in the past 12 months up to July 2026

Total visits to Novartis's top domains

Understand Novartis market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Novartis's top domains

Analyze Novartis engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Novartis's top domains

See how Novartis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Novartis top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Novartis

These are the website technologies, by industry, used by Novartis top domains

Advertising (11)

DoubleClick

Social (5)

Instagram

Conversion & Analytics (4)

Google Analytics

Widget (4)

reCAPTCHA

More Technologies

8

See all

News & Signals from Novartis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioNTech US Inc. partners with Novartis AG.BioNTech has entered into an agreement with Novartis to acquire one of its good manufacturing practice (GMP)-certified manufacturing facilities.

NewsDocquity Holdings Pte. Ltd. partners with Novartis AG.Singapore based startup Docquity, Southeast Asia's largest professional network of doctors, has partnered with Swiss research-based healthcare company Novartis to deliver bite-sized, continual learning, and education support to doctors across seven countries in Asia.

NewsNovartis AG invested into Pear Therapeutics, Inc. $64M on Jan 4th '19.Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that it has successfully closed a $64 million Series C financing led by Temasek, and joined by other existing investors including Novartis, 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative, and Singapore-based EDBI.